Adrenal Insufficiency Caused by Chronic Corticosteroid Use, Identified through Medication Therapy Management

2021 ◽  
Vol 36 (1) ◽  
pp. 22-33
Author(s):  
Tsuhua Susan Chen ◽  
Shilun David Li

OBJECTIVE: To report a case of adrenal insufficiency caused by chronic corticosteroid treatment.Summary: This case study describes a 71-year-old Caucasian woman diagnosed with secondary adrenal insufficiency (SAI). She had a long history of multiple medical problems that affected her quality of life. The pharmacist reviewed 18 years (2001-2018) of medical records, including her corticosteroid usage history. The patient had been receiving chronic medium-high dose inhaled corticosteroids for asthma, with intermittent oral prednisone for exacerbations. The pharmacist suspected a possible SAI or tertiary adrenal insufficiency (TAI) caused by hypothalamic pituitary adrenal axis suppression induced by chronic corticosteroid use. After discussions with the patient's primary care physician and a screening adrenal function test, the patient was referred to an endocrinologist, and the diagnosis was confirmed. Low-dose hydrocortisone (<30 mg daily) was prescribed; the patient had improvements in mood, skin hyperpigmentation, and asthma symptoms, which eliminated the routine visits to the emergency room/clinic during the winter season.CONCLUSION: The case illustrated the benefits of utilizing a pharmacist's expertise. A consultant pharmacist can identify an underdiagnosed and rare condition, corticosteroid-induced adrenal insufficiency, through comprehensive medication review in a community medication therapy management service setting.

2021 ◽  
Vol 36 (1) ◽  
pp. 22-33
Author(s):  
Tsuhua Susan Chen ◽  
Shilun David Li

Objective: To report a case of adrenal insufficiency caused by chronic corticosteroid treatment. Summary: This case study describes a 71-year-old Caucasian woman diagnosed with secondary adrenal insufficiency (SAI). She had a long history of multiple medical problems that affected her quality of life. The pharmacist reviewed 18 years (2001-2018) of medical records, including her corticosteroid usage history. The patient had been receiving chronic medium-high dose inhaled corticosteroids for asthma, with intermittent oral prednisone for exacerbations. The pharmacist suspected a possible SAI or tertiary adrenal insufficiency (TAI) caused by hypothalamic pituitary adrenal axis suppression induced by chronic corticosteroid use. After discussions with the patient’s primary care physician and a screening adrenal function test, the patient was referred to an endocrinologist, and the diagnosis was confirmed. Low-dose hydrocortisone (<30 mg daily) was prescribed; the patient had improvements in mood, skin hyperpigmentation, and asthma symptoms, which eliminated the routine visits to the emergency room/ clinic during the winter season. Conclusion: The case illustrated the benefits of utilizing a pharmacist’s expertise. A consultant pharmacist can identify an underdiagnosed and rare condition, corticosteroid-induced adrenal insufficiency, through comprehensive medication review in a community medication therapy management service setting.


Author(s):  
Pedro Augusto do Amaral ◽  
Simone de Araújo Medina Mendonça ◽  
Djenane Ramalho de Oliveira ◽  
Leonardo José Peloso ◽  
Reginaldo dos Santos Pedroso ◽  
...  

2015 ◽  
Vol 18 (10) ◽  
pp. 828-837 ◽  
Author(s):  
Fadia T. Shaya ◽  
Viktor V. Chirikov ◽  
Charmaine Rochester ◽  
Roxanne W. Zaghab ◽  
Kathrin C. Kucharski

2010 ◽  
Vol 50 (1) ◽  
pp. 72-81a ◽  
Author(s):  
Megan Friedrich ◽  
David Zgarrick ◽  
Amir Masood ◽  
Jaime Montuoro

2016 ◽  
Vol 134 ◽  
pp. 109-119 ◽  
Author(s):  
Chang-Ming Chen ◽  
Li-Na Kuo ◽  
Kuei-Ju Cheng ◽  
Wan-Chen Shen ◽  
Kuan-Jen Bai ◽  
...  

Author(s):  
Jennifer M. Bingham ◽  
Jennifer Stanislaw ◽  
Terri Warholak ◽  
Nicole Scovis ◽  
David R. Axon ◽  
...  

(1) Background: Regular contact with a medication therapy management (MTM) pharmacist is shown to improve patients’ understanding of their condition; however, continued demonstration of the value of a pharmacist delivered comprehensive medication review (CMR) using enhanced MTM services via telehealth is needed. The study aimed to describe a pilot program designed to improve type 2 diabetes mellitus (T2DM) management through enhanced condition specific MTM services. (2) Methods: This retrospective study included patients with T2DM aged 40–75 years who received a pharmacist-delivered CMR between January and December 2018. An evaluation of glycosylated hemoglobin (HbA1c) values 3 months pre- and post-CMR was performed. Wilcoxon signed-rank and chi-square tests were used. (3) Results: Of 444 eligible patients, a majority were female (58%) with a median age of 70 years. Median HbA1c values post-CMR were lower than pre-CMR (median 7.1% range 4.5–13.6; median 7.4% range 4.5–13.9, respectively; p = 0.009). There were fewer participants with HbA1c >9% post-CMR (n = 66) than pre-CMR (n = 80; p < 0.001) and more with HbA1C <6.5% post-CMR (n = 151) than pre-CMR (n = 130; p < 0.001). (4) Conclusion: This program evaluation highlighted the value of an enhanced condition specific MTM service via telehealth. Patients had improved HbA1c values three months after receiving a single pharmacist delivered CMR.


Sign in / Sign up

Export Citation Format

Share Document